Correlation between thrombophilia and recurrent pregnancy loss in patients with polycystic ovary syndrome: A comparative study

Journal of the Chinese Medical Association

Volumn 76, Issue 5, 2013, Pages 282-288

  Kazerooni, Talieh ^a   Ghaffarpasand, Fariborz ^a,b   Asadi, Nasrin ^a   Dehkhoda, Zahra ^a   Dehghankhalili, Maryam ^a,c   Kazerooni, Yasaman ^d  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d NEW MEXICO INSTITUTE OF MINING AND TECHNOLOGY   (United States)

Author keywords

Polycystic ovary syndrome (PCOS); Recurrent pregnancy loss (RPL); Thrombophilia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; HOMOCYSTEINE; INSULIN; PROTHROMBIN; TESTOSTERONE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; EMBRYO DEATH; FEMALE; GENE MUTATION; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PROTEIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; THROMBOPHILIA;

ABORTION, HABITUAL; ADULT; CASE-CONTROL STUDIES; FACTOR V; FEMALE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYCYSTIC OVARY SYNDROME; PREGNANCY; THROMBOPHILIA;

EID: 84877824653     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2013.01.009     Document Type: Article

References (32)

1. Asunción M., Calvo R.M., San Millán J.L., Sancho J., Avila S., Escobar-Morreale H.F. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000, 85:2434-2438.
2. Diamanti-Kandarakis E., Kouli C.R., Bergiele A.T., Filandra F.A., Tsianateli T.C., Spina G.G., et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999, 84:4006-4011.
3. Brassard M., AniMelk Y., Baillargeon J.P. Basic infertility including polycystic ovary syndrome. Med Clin North Am 2008, 92:1163-1192.
4. Wang J.X., Davies M.J., Norman R.J. Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. Hum Reprod 2001, 16:2606-2609.
5. Glueck C.J., Phillips H., Cameron D., Sieve-Smith L., Wang P. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil Steril 2001, 75:46-52.
6. Velazquez E.M., Mendoza S.G., Wang P., Glueck C.J. Metformin therapy is associated with decreased plasma plasminogen activator inhibitor-1, lipoprotein (a) and immunoreactive insulin levels in patients with the polycystic ovary syndrome. Metabolism 1997, 46:454-457.
7. Bertina R.M. Molecular risk factors for thrombosis. Thromb Haemost 1999, 82:601-609.
8. Dahlback B. New molecular insights into genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis. Thromb Haemost 1995, 74:139-148.
9. Poort S.R., Rosendaal F.R., Reitsma P.H., Bertina R.M. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma levels and an increase in venous thrombosis. Blood 1996, 88:3698-3703.
10. Arruda V.R., von Zuben P.M., Chiaparini L.C., Annichino-Bizzacchi J.M., Costa F.F. The mutation Ala677→Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb Haemost 1997, 77:818-821.
11. Kupferminc M.J., Eldor A., Steinman N., Many A., Bar-Am A., Jaffa A., et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1994, 240:9-19.
12. Rodger M.A., Paidas M., McLintock C., Middeldorp S., Kahn S., Martinelli I., et al. Inherited thrombophilia and pregnancy complications revisited. Obstet Gynecol 2008, 112:320-324.
13. Rai R., Backos M., Rushword F., Regan L. Polycystic ovaries and recurrent miscarriage a reappraisal. Hum Reprod 2000, 15:612-615.
14. Glueck C.J., Awadalla S.G., Phillips H., Cameron D., Wang P., Fontaine R.N. Polycystic ovarian syndrome, infertility, familial thrombophilia, familial hypofibrinolysis, recurrent loss of in vitro fertilized embryos, and miscarriage. Fertil Steril 2000, 74:394-397.
15. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81:19-25. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.
16. Azziz R., Dewailly D., Owerbach D. Nonclassic adrenal hyperplasia: current concepts. J Clin Endocrinol Metab 1994, 78:810-815.
17. White P.C., Curnow K.M., Pascoe L. Disorders of steroid 11β-hydroxylase isozymes. Endocr Rev 1994, 15:421-438.
18. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000, 85:2402-2410.
19. Legro R.S., Finegood D., Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998, 83:2694-2698.
20. Zoller B., Svensson P.J., He X., Dahlback B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994, 94:2521-2524.
21. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995, 10:111-113.
22. Glueck C.J., Wang P., Bornovali S., Goldenberg N., Sieve L. Polycystic ovary syndrome, the G1691A factor V Leiden mutation, and plasminogen activator inhibitor activity: associations with recurrent pregnancy loss. Metabolism 2003, 52:1627-1632.
23. Glueck C.J., Wang P., Fontaine R.N., Sieve-Smith L., Tracy T., Moore S.K. Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in patients with polycystic ovary syndrome. Metabolism 1999, 48:1589-1595.
24. Tsanadis G., Vartholomatos G., Korkontzelos I., Avgoustatos F., Kakosimos G., Sotiriadis A., et al. Polycystic ovarian syndrome and thrombophilia. Hum Reprod 2002, 17:314-319.
25. Glueck C.J., Goldenberg N., Wang P., Loftspring M., Sherman A. Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum Reprod 2004, 19:510-521.
26. Glueck C.J., Wang P., Goldenberg N., Sieve-Smith L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod 2002, 17:2858-2864.
27. Kazerooni T., Ghaffarpasand F., Kazerooni Y., Kazerooni M., Setoodeh S. Short-term metformin treatment for clomiphene citrate-resistant women with polycystic ovary syndrome. Int J Gynecol Obstet 2009, 107:50-53.
28. Balasa V.V., Gruppo R.A., Glueck C.J., Stroop D., Becker A., Pillow A., et al. The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults. Thromb Haemost 1999, 81:739-744.
29. Giltay E.G., Hoogeveen E.K., Elbers J.M., Gooren L.J., Asscherman H., Stehouwer C.D. Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, nonobese subjects. Atherosclerosis 2001, 139:197-198.
30. Glueck C.J., Phillips H., Cameron D., Wang P., Fontaine R.N., Moore S.K., et al. The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications. Metabolism 2000, 49:845-852.
31. Martinelli I., Destefano V., Taioli E., Paciaroni K., Rossi E., Mannucci P.M. Inherited thrombophilias and first venous thromboembolism during pregnancy and puerperium. Thromb Haemost 2002, 87:791-795.
32. Behjati R., Modarressi M.H., Jeddi-Tehrani M., Dokoohaki P., Ghasemi J., Zarnani A.H., et al. Thrombophilic mutations in Iranian patient with infertility and recurrent spontaneous abortion. Ann Hematol 2006, 85:268-271.